The effectiveness of three different doses of extradural morphine (4,6 and 8 mg) in relieving post-operative pain was compared in 24 patients. Although there was no significant difference in the efficacy of the three doses, increasing dosage increased the average duration of analgesia provided by the drug (4 mg-593 min; 6 mg-722 min; 8 mg-885 min). All three doses increased the average peak expiratory flow rate, the greatest increases being seen at the higher dosages. Increasing dosage was not accompanied by an increase in the occurrence of adverse effects.
There are now numerous reports in the literature describing the effectiveness of extradural morphine in relieving post-operative pain (Magora et al., 1980; Bromage, Camporesi and Chestnut, 1980; Torda and Pybus, 1981) . Although there appears to be a uniformity of opinion regarding the efficacy of the technique, there is no agreement as to what constitutes the optimal dose of the drug when administered in this fashion. Whereas the early investigators (Beharetal., 1979) recommended a dose of 2-3 mg, the more recent trend has been towards using higher doses in the range 5-10 mg (Bromage, Camporesi and Chestnut, 1980; Weddel and Ritter, 1980) . The present study was devised to explore the dose-effect relationships of extradural morphine with particular reference to the duration and quality of analgesia and to the physiological effects produced by differing doses of the drug.
MATERIALS AND METHODS
As with a previous study (Torda and Pybus, 1982) the design adopted was that of a "within patient" controlled trial, which had been approved by the Clinical Trials Committee of our hospital. All the participating patients were admitted to the Intensive Care Unit following major thoracic or abdominal surgery and all gave their informed consent to be studied. In each patient, three different doses of extradural morphine (4,6 and 8 mg diluted to 10 ml in normal saline) were compared.
In order to eliminate effects of the order of ad- ministration of the various doses, each of the six possible sequences of administration of the three doses was given to four patients, so that in all, 24 patients were required to complete the study. In order to complete these 24 studies, 57 studies were attempted: In 2 patients the trial was abandoned because of a sudden deterioration in their condition which was unrelated to the method of analgesia (post-operative haemorrhage, cardiac arrest). In 9 patients only a single dose of extradural morphine was required so no useful data were derived.
In 19 patients, incomplete data were recorded either because they were discharged from Intensive Care before completion of the study (4) or because four doses of analgesic were not required (15). In another 3 patients doses were administered in incorrect order. Data from these 22 patients are recorded in table II, as "incomplete trials".
In the 24 completed studies, there were 14 males and 10 females and these patients ranged in age from 17 to 72 years and in weight from 35 to 90 kg. Following opiate premedication in all patients, general anaesthesia was induced with thiopentone and maintained with nitrous oxide in oxygen, supplemented by a muscle relaxant and intermittent doses of fentanyl. In some patients, halothane was also used. Extradural catheters were inserted at a spinal level appropriate to the surgery performed, either under anaesthesia or shortly after arrival in the Intensive Care Unit. In seven patients, who underwent major urological surgery, the catheters were at the L2-3 or L3-4 level, and these patients were given extradural bupivacaine during the course of surgery. In the remaining 17 patients the catheters were placed between T4 and T10 and no local © The Macmillan Press Ltd 1982 anaesthetic was used unless there was doubt about the placement of the catheter. In these latter cases, 5 ml of 2% lignocaine was administered and the patient subsequently tested for a band of sensory loss. As soon as the patient complained of pain, he was given an extradural injection of 4, 6 or 8 rug of morphine sulphate diluted to 10 ml in normal saline. The patients were told that the injection would take 45 minutes to achieve a maximal effect and that thereafter they would be given further doses at their request. Immediately before and 45-60 minutes after the injection observations of vital signs and peak expiratory flow rate (PEFR) were made. The severity of the patients' pain was scored according to a simple scale shown in table I. Complaints of nausea, itching and the occurrence of urinary retention or of vomiting were noted, as were other adverse effects attributable to the technique.
The data were analysed using the following techniques: the durations of action of the three doses were compared using the Mann Whitney rank sum test. The values of the vital signs and PEFR before and after drug administration were analysed using the paired t test. The differences between the effects of the three doses were contrasted using the f statistic for two samples. The significance of differences in the pain scores was assessed using the "Chi squared" test. Correlations between age, weight and duration of analgesia provided by the various doses were tested by the product-moment formula. In all cases findings were considered significant if P < 0.05.
RESULTS
When the trial group alone was considered, the mean duration of action of a 4 mg dose of morphine was 593 minutes, 6 mg, 722 minutes and 8 mg, 885 minutes. The duration of analgesia provided by the 4 mg dose was significantly shorter than that provided by the 8 mg dose, but no other difference was significant. In the 22 patients in whom the trial was not completed the mean duration of action of each dose was longer than in those who completed the trial, but the difference was not significant. When the two groups were combined, the results again did not differ significantly from the completed trials (table II) . As expected, the mean duration of action of the first dose, 601 minutes, was shorter than that of the second, 667 minutes, which in turn was shorter than that of the third dose of morphine, 933 minutes. The difference between the first and third doses was significant (P < 0.0 5).
The effects of the three doses on heart rate, respiration, arterial pressure and PEFR are shown in table III.
Heart rates were not significantly altered by any of the three doses. All doses reduced the mean respiratory rate slightly, but in only the 6 and 8 mg dosage was this reduction significant. The decrease in respiratory rate was generally slight and in no patient was a rate less than 14 per minute recorded. Systolic arterial pressure was unaffected by the 8 mg dose of morphine, but was statistically significantly reduced by the 4 and 6mg doses. In these latter groups, the mean reduction of systolic pressure was less than 10 mm Hg. The largest recorded decrease in any individual was from 210 mm Hg to 155 mm Hg. There was no significant effect on diastolic arterial pressure. PEFR increased following all three dosages, and this increase was significant (P<0.01) following the 6 and 8 mg doses. There was no significant difference between the pain scores recorded following the three doses of morphine ( fig. 1 ). Of the 72 observations of pain score in the 24 "trial completed" patients, there were 15 scores of 3 in 9 patients and no scores of 4 were recorded. Three of the patients had scores of 3 throughout the trial, one patient scored 3 on two doses and four patients scored 3 on one dose only.
The duration of analgesia provided by the various doses did not correlate with either the age or weight of the patients.
Among the 24 patients who completed the trial the following side-effects were noted. Nausea and vomiting occurred in one patient only, after arrival in the Intensive Care Unit. She vomited after the first and second opiate doses (4 and 6 mg), but not after the third. Two patients complained of itching, diminished but not completely relieved by naloxone in one and promethazine in the other. The patient given naloxone complained of feeling restless and unwell after its administration. Eight patients of the 24 arrived in the Unit without bladder catheters. Two of these patients, who had undergone thoracotomy and had extradural catheters inserted at T5-6, developed retention and required catheters. One had received 6, the other 8 mg morphine. DISCUSSION Before discussion of the results presented, there are three points pertaining to methods which require mention. First, the "Latin Square" design appears to be justified by the demonstrated increase in duration of action of the second and third doses. Had a random design been used it would have been possible that a bias because of the order of administration of the three doses could have affected the result. In a sample as small as this study, it would have been serendipitous had an equal representation of the three doses appeared in a randomized sequence of three administrations.
The second point for discussion concerns the effect of the subjects who failed to complete the trial. The possibility exists that these subjects could bias the results by excluding those who obtained the longest period of pain relief. Comparison of the mean durations for the "trial completed" group and "all trials" demonstrates that this effect was minor.
We also wish to draw attention to the pain score system used in this study. The end-points are objectively defined and very easy to apply to subjects who have pain on breathing. Apart from the authors, three Resident Medical Officers and several nursing staff recorded observations and appeared to do so with a high degree of reproducibility. We suggest that this scoring system offers advantages over those previously described for the study of post-operative pain following abdominal or thoracic surgery. The system has proved particularly useful in patients who cannot co-operate in scoring a visual analogue scale.
Although initially a dose of only 2 mg was used in our unit (Torda, 1979) , it soon became apparent that in patients with post-operative pain the quality of relief offered by a 4mg dose was obviously better (Torda and Pybus, 1981) . As there was no increase noted in liability to adverse effects, it was not considered ethically justifiable to explore the dose range below 4mg. Our findings now indicate that a 4mg dose of cxtradural morphine is as efficacious as 6 or 8 mg in relieving post-operative pain in patients not accustomed to opiates. Fifteen (62.5%) of the patients were pain free at rest for the duration of the trial period (except for short intervals at "top-up" time) and a further 6 were pain free at rest following at least one of the doses. Increasing the dose from 4 to 8mg did however increase the duration of analgesia, and the PEFR without any apparent increase in the frequency of adverse effects, respiratory, circulatory or otherwise. These results appear to indicate that 4 mg is probably capable of saturating the analgesic receptors available to extradurally administered morphine. The findings of this study should not be applied to patients tolerant to narcotic analgesics who, in our experience, tolerate and require larger doses.
